Ken Shimamura
Diagnostic, Research & Development Lead Pfizer
Ken Shimamura leads Pfizer’s companion diagnostic strategy for oncology and non-oncology portfolio in Japan’s development team. He establishes key strategic partnerships with Dx companies and proposes effective Dx development & launch strategies to Japan and global team based on regulation and market view.
Seminars
Tuesday 19th May 2026
Aligning Global CDx Strategy: Integrating Japan into Worldwide Clinical Development
9:00 am
- Harmonizing companion diagnostics strategy across Japan, Europe, China, and the US to ensure global clinical and regulatory alignment
- Designing global clinical trials to support CDx development, ensuring coordination between regional diagnostics and global clinical leads
